STOCKSCREENR
Log In

IMMP

NASDAQ

Immutep Limited

$0.41-0.06(-12.96%)Mkt Cap: $59.61M

Key Stats

Market Cap

$59.61M

P/E Ratio

-5.79

EPS

$-0.07

Dividend Yield

0.00%

52-Week Range

$0.40 — $3.53

Volume

3.91M

Avg Volume

1.18M

Beta

1.64

Valuation

P/E (TTM)

-5.79

Forward P/E

—

PEG Ratio

0.19

P/S (TTM)

97.28

P/B (TTM)

5.87

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.69%

ROA (TTM)

-0.57%

ROIC

—

Gross Margin

-5.23%

Operating Margin

-20.52%

Net Margin

—

Debt/Equity

0.02

Current Ratio

2.97

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.06%

EPS Growth (5Y)

-0.08%

Sales Growth (3Y)

+6.66%

Sales Growth (5Y)

+3.71%

EPS Est (This Year)

$-0.45

EPS Est (Next Year)

$-0.56

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.07

Analyst Consensus

Price Target Range

$3.50$4.25$5.00
LowMedianHigh

Consensus Target: $4.25(949.4% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

147.19M

Float

146.13M

Free Float %

99.28%

About

Sector

Healthcare

Industry

Biotechnology

Country

AU

Exchange

NASDAQ

IPO Date

2012-04-19

Employees

41

CEO

Marc Voigt

Index Membership

—

Website

https://www.immutep.com

Immutep Limited (IMMP) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $59.61M, a P/E ratio of -5.79, IMMP is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare IMMP against other stocks using dozens of fundamental and technical filters.

Similar Stocks

FRX.TO

Fennec Pharmaceuticals Inc.

$10.72

-0.05%

$295.33M

OBI.L

Ondine Biomedical Inc.

$11.00

+0.00%

$47.11M

IMAB

I-Mab

$2.90

+2.47%

$237.29M

OABI

OmniAb, Inc.

$1.83

+0.00%

$208.29M

CGEN

Compugen Ltd.

$2.27

+0.00%

$214.64M

CNTN

Canton Strategic Holdings Inc

$3.95

-2.47%

$156.14M

Frequently Asked Questions

What is Immutep Limited's P/E ratio?

Immutep Limited (IMMP) has a trailing twelve-month (TTM) P/E ratio of -5.79. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Immutep Limited pay a dividend?

No, Immutep Limited (IMMP) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Immutep Limited's market cap?

Immutep Limited (IMMP) has a market capitalization of $59.61 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.